RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression

被引:0
|
作者
Mei Wang
Yanyan Zhang
Zhi Xu
Peipei Qian
Wenbo Sun
Xiumei Wang
Zhang Jian
Tiansong Xia
Yong Xu
Jinhai Tang
机构
[1] The First Affiliated Hospital with Nanjing Medical University,Department of General Surgery
[2] Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University,Breast Disease Center
[3] The First Affiliated Hospital with Nanjing Medical University,Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment
[4] Nanjing Medical University,Department of Toxicology and Cancer Biology
[5] University of Kentucky Markey Cancer Center,undefined
关键词
RelB; EMT; MMP1; Cancer progression and breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Epsin promotes breast cancer progression and metastasis by controlling nf-κb activation
    Cai, Xiaofeng
    Chen, Hong
    CANCER RESEARCH, 2014, 74 (19)
  • [22] NF-κB activation in development and progression of cancer
    Inoue, Jun-ichiro
    Gohda, Jin
    Akiyama, Taishin
    Semba, Kentaro
    CANCER SCIENCE, 2007, 98 (03): : 268 - 274
  • [23] Mammaglobin 1 mediates progression of trastuzumab-resistant breast cancer cells through regulation of cyclins and NF-κB
    Kusumastuti, Ratih
    Kumagai, Yuji
    Ishihara, Seiichiro
    Enomoto, Atsushi
    Murakami, Takashi
    Yasuda, Motoaki
    Haga, Hisashi
    FEBS OPEN BIO, 2022, 12 (10): : 1797 - 1813
  • [24] NF-κB signaling promotes castration-resistant prostate cancer initiation and progression
    Thomas-Jardin, Shayna E.
    Dahl, Haley
    Nawas, Afshan F.
    Bautista, Monica
    Delk, Nikki A.
    PHARMACOLOGY & THERAPEUTICS, 2020, 211
  • [25] NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
    Uno, Masaya
    Saitoh, Yasunori
    Mochida, Kanako
    Tsuruyama, Eri
    Kiyono, Tohru
    Imoto, Issei
    Inazawa, Johji
    Yuasa, Yasuhito
    Kubota, Toshiro
    Yamaoka, Shoji
    PLOS ONE, 2014, 9 (02):
  • [26] ADAM9 Mediates Triple-Negative Breast Cancer Progression via AKT/NF-κB Pathway
    Zhou, Rui
    Cho, William C. S.
    Ma, Victor
    Cheuk, Wah
    So, Yik-Ka
    Wong, S. C. Cesar
    Zhang, Mingrong
    Li, Cong
    Sun, Yujie
    Zhang, Hong
    Chan, Lawrence W. C.
    Tian, Mei
    FRONTIERS IN MEDICINE, 2020, 7
  • [27] Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF-κB pathway (Review)
    Wang, Xiumei
    Fang, Yao
    Sun, Wenbo
    Xu, Zhi
    Zhang, Yanyan
    Wei, Xiaowei
    Ding, Xuansheng
    Xu, Yong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (05) : 1064 - 1074
  • [28] Targeting the NF-κB Pathway in Cancer Therapy
    Erstad, Derek J.
    Cusack, James C., Jr.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (04) : 705 - +
  • [29] The alternative NF-κB pathway, via NIK and RelB, mediates tumor-induced osteolysis
    Novack, D.
    Vaira, S.
    Hirbe, A. C.
    Johnson, T.
    Alhawagri, M.
    Weilbaecher, K. N.
    Guarini, A.
    Faccio, R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 24 - 24
  • [30] The NF-κB Pathway and Cancer Stem Cells
    Rinkenbaugh, Amanda L.
    Baldwin, Albert S.
    CELLS, 2016, 5 (02)